Aarti Drugs Ltd

Aarti Drugs Limited, established in 1984 and headquartered in Mumbai, India, is a prominent global player in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals. As part of the diversified Aarti Group of Industries, the company has built a formidable reputation for its scale, cost-efficiency, and deep expertise in complex chemical synthesis.

Aarti Drugs operates multiple state-of-the-art manufacturing facilities situated in the industrial hubs of Tarapur and Sarigam in India, all designed to meet stringent global regulatory standards. The company is a dominant global supplier in several therapeutic categories, holding significant market share in antibiotics (particularly fluoroquinolones like Ciprofloxacin and Ofloxacin), antidiarrheals, anti-inflammatory drugs, and cardioprotectants.

By backward integrating its supply chain and manufacturing key raw materials in-house, Aarti Drugs ensures uninterrupted supply, consistent quality, and competitive pricing for its clients worldwide. The company is heavily focused on Research and Development, operating recognized R&D centers that continuously work on process optimization, yield improvement, and the development of non-infringing processes for upcoming generic molecules.

This strong technical foundation enables Aarti Drugs to cater to the demanding requirements of pharmaceutical formulations manufacturers in over 100 countries across the globe. Quality assurance is paramount, with facilities holding certifications from prestigious regulatory authorities such as the US FDA, WHO GMP, and EDQM. Through a relentless focus on operational excellence, sustainable manufacturing practices, and capacity expansion, Aarti Drugs continues to solidify its position as a reliable and strategic API supplier in the global healthcare supply chain.